Nuevas formas de manejo de la miocardiopatía dilatada familiar: utilidad del estudio genético en la práctica clínica

Cardiocore - Tập 52 - Trang 75-79 - 2017
Laura Jordán-Martínez1, Miguel A. López-Garrido1, Noemí González-Cruces1, María P. Cardila-Cruz1, Daniel J. Elena-Aldana1, José M. García-Pinilla1, Amalio Ruiz-Salas1, Luis Morcillo-Hidalgo1, Juan J. Gómez-Doblas1, Eduardo de Teresa-Galván1
1Unidad de Insuficiencia Cardíaca y Cardiopatías Familiares, Área del Corazón, Hospital Universitario Virgen de la Victoria, Campus Universitario de Teatinos, Málaga, España

Tài liệu tham khảo

Elliott, 2008, Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J., 29, 270, 10.1093/eurheartj/ehm342 McNally, 2013, Genetic mutations and mechanisms in dilated cardiomyopathy, J Clin Invest., 123, 19, 10.1172/JCI62862 Meder, 2014, A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy, Eur Heart J., 35, 1069, 10.1093/eurheartj/eht251 García-Pavía, 2013, Genetics in dilated cardiomyopathy, Biomark Med., 7, 517, 10.2217/bmm.13.77 Sturm, 2013, Genetic testing in cardiovascular medicine: Current landscape and future horizons, Curr Opin Cardiol., 28, 317, 10.1097/HCO.0b013e32835fb728 López-Haldón, 2014, Genética para cardiólogos, Cardio Core., 49, 47, 10.1016/j.carcor.2014.02.004 Cobo-Marcos, 2014, Aplicación práctica de la genética en el manejo de las miocardiopatías, Cardio Core., 49 Tester, 2011, Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice, Circulation., 123, 1021, 10.1161/CIRCULATIONAHA.109.914838 Haas, 2015, Atlas of the clinical genetics of human dialted cardiomyopathy, Eur Heart J., 36, 1123, 10.1093/eurheartj/ehu301 Capriotti, 2011, Improving the prediction of disease-related variants using protein three-dimensional structure, BMC Bioinformatics., 12, S3, 10.1186/1471-2105-12-S4-S3 Waldmüller, 2011, Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: Results from the German Competence Network Heart Failure, Eur J Heart Fail., 13, 1185, 10.1093/eurjhf/hfr074 Van Rijsingen, 2013, Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers, Eur J Heart Fail., 15, 376, 10.1093/eurjhf/hfs191 Brauch, 2009, Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy, J Am Coll Cardiol., 54, 930, 10.1016/j.jacc.2009.05.038 Refaat, 2012, Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy, Heart Rhythm., 9, 390, 10.1016/j.hrthm.2011.10.016 Charron, 2010, Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J., 31, 2715, 10.1093/eurheartj/ehq271 Burkett, 2005, Clinical and genetic issues in familial dilated cardiomyopathy, J Am Coll Cardiol, 45, 969, 10.1016/j.jacc.2004.11.066 Cobo-Marcosa, 2013, Utilidad del análisis genético de la miocardiopatía hipertrófica en la práctica real, Rev Esp Cardiol., 66, 746, 10.1016/j.recesp.2013.04.004